Sensor Interface Application Authentication for Secure Glucose Display

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Individuals with diabetes often fail to monitor their glucose levels frequently due to convenience, testing discretion, pain, and cost, leading to inadequate glycemic control.

Innovation Solution

In vivo analyte monitoring systems with integrated sensor control devices and reader devices that authenticate and control the interfacing between applications on mobile devices, ensuring secure and timely display of analyte levels, including methods for user interface application authentication, data processing, and critical event notification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If in vivo analyte monitoring systems are implemented, then glucose monitoring frequency and reliability are improved, but device complexity and cost increase

Engineering Contradiction:
Improveglucose monitoring reliabilityVSAvoidmonitoring system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The monitoring system is divided into separate functional modules: sensor control device implanted in vivo for data collection, reader device for data reception and processing, and mobile device with dedicated applications for user interface and data management. This segmentation allows each component to be optimized independently, improving overall reliability while managing complexity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A reader device acts as an intermediary between the implanted sensor control device and the mobile device. It receives data from the sensor, processes it, and transmits it to the mobile device, thereby decoupling the complex sensing operations from the user interface and simplifying the overall system architecture.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If multiple applications are allowed to interface with sensor data, then user convenience and application versatility improve, but data security and system reliability deteriorate

Engineering Contradiction:
Improveapplication interoperabilityVSAvoiddata security
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The system performs preliminary authentication of third-party applications before granting access to sensor data. The sensor interface application verifies the legitimacy of requesting applications and establishes secure communication channels in advance, ensuring data security is maintained while allowing multiple approved applications to interface with the system.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements a feedback mechanism where the sensor interface application monitors and controls access to sensor data based on application authentication status. Approved applications receive necessary data while unapproved applications are denied access, thereby maintaining security while enabling versatile application support.

Inventive Principle:
Principle #23Feedback

3Productivity

If real-time analyte data is continuously displayed, then glycemic control effectiveness improves, but energy consumption and device complexity increase

Engineering Contradiction:
Improveglycemic control effectivenessVSAvoidmobile device energy consumption
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

Instead of continuous real-time display, the system updates analyte data at periodic intervals determined by the sensor broadcast schedule and application logic. This periodic updating maintains effective glycemic control by providing timely data while significantly reducing energy consumption compared to continuous display refreshes.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS12411930B2Application interface and display control in an analyte monitoring environment
Publication Date: 2025.09.09 ABBOTT DIABETES CARE INC
  • US12411930B2 patent drawing
  • US12411930B2 patent drawing
  • US12411930B2 patent drawing

AI summary

Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.